Dianthus Therapeutics DNTH Peer Comparison

NASDAQ DNTH
$107.64 -0.21 (-0.19%)
As of: Sep 4, 2026 · 12:45 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

Dianthus Therapeutics, Inc. /DE/ (DNTH) is the 46th largest of 300 Biotechnology companies by market capitalisation, at 4.07 Bn, behind Denali Therapeutics Inc. at 4.17 Bn. The table below compares all 300 on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 236.40 Bn 0.00 Mn 6.21 222.41 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 187.88 Bn 0.00 Mn 6.17 184.70 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 139.76 Bn 0.00 Mn 11.10 131.91 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 85.72 Bn 0.00 Mn 5.52 77.72 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 63.56 Bn 0.00 Mn 12.16 58.38 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 57.87 Bn 0.00 Mn 25.97 52.73 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 35.50 Bn 0.00 Mn 7.39 32.20 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 32.59 Bn 0.00 Mn 3.25 31.31 Bn
9 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.49 Bn 0.00 Mn 24.16 26.33 Bn
10 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 25.23 Bn 0.00 Mn 8.16 11.57 Bn
11 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 24.81 Bn 0.00 Mn 2,270.94 24.81 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 16.23 Bn 0.00 Mn 13.29 15.28 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.95 Bn 0.00 Mn 12.42 15.11 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.55 Bn 0.00 Mn 20.40 13.83 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.54 Bn — — 12.85 Bn
16 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.91 Bn 0.00 Mn 7.76 12.68 Bn
17 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.86 Bn 0.00 Mn 3.78 11.99 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.13 Bn 0.00 Mn 18.12 10.53 Bn
19 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.27 Bn 0.00 Mn — 9.51 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn 0.00 Mn — 9.20 Bn
21 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.75 Bn 0.00 Mn 11.15 7.69 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.62 Bn 0.00 Mn 34.12 9.62 Bn
23 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.83 Bn 0.00 Mn — 8.83 Bn
24 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.53 Bn 0.00 Mn 51.43 8.17 Bn
25 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.02 Bn 0.00 Mn — 8.02 Bn
26 ABVX Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.00 Bn 0.00 Mn — 8.00 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.95 Bn 0.00 Mn 9.94 7.27 Bn
28 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.34 Bn 0.00 Mn — 7.34 Bn
29 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.22 Bn 0.00 Mn — 7.22 Bn
30 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.05 Bn 0.00 Mn 29.38 6.72 Bn
31 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.68 Bn 0.00 Mn 4,799.49 6.68 Bn
32 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.53 Bn 0.00 Mn 1,048.69 6.53 Bn
33 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.41 Bn 0.00 Mn 10.37 5.97 Bn
34 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 6.11 Bn 0.00 Mn 7.27 5.59 Bn
35 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.93 Bn 0.00 Mn — 5.93 Bn
36 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.92 Bn 0.00 Mn — 5.92 Bn
37 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.87 Bn 0.00 Mn 1,169.14 5.69 Bn
38 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.81 Bn — — 4.08 Bn
39 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 0.00 Mn 5.75 3.58 Bn
40 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn 0.00 Mn 19.83 4.40 Bn
41 GRFS Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 5.31 Bn 0.00 Mn 0.32 4.15 Bn
42 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.19 Bn 0.00 Mn — 5.19 Bn
43 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.03 Bn 0.00 Mn — 5.03 Bn
44 RADX Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.35 Bn 0.00 Mn 20,980.03 4.35 Bn
45 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.17 Bn 0.00 Mn 1,156.94 4.17 Bn
46 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 4.07 Bn — — 3.66 Bn
47 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.04 Bn 0.00 Mn — 4.04 Bn
48 TLX Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 4.03 Bn — — 3.74 Bn
49 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.99 Bn 0.00 Mn — 3.99 Bn
50 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.81 Bn 0.00 Mn 368.07 3.81 Bn
51 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.79 Bn 0.00 Mn — 3.79 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.73 Bn 0.00 Mn 31.90 3.03 Bn
53 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.65 Bn 0.00 Mn 15.59 2.82 Bn
54 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.48 Bn 0.00 Mn 52.62 3.48 Bn
55 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.37 Bn 0.00 Mn 62.67 2.36 Bn
56 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.10 Bn 0.00 Mn 6.69 2.86 Bn
57 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.08 Bn 0.00 Mn — 3.08 Bn
58 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.07 Bn 0.00 Mn 19,440.29 3.07 Bn
59 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.05 Bn 0.00 Mn 593.06 2.53 Bn
60 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.92 Bn 0.00 Mn — 2.92 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.89 Bn 0.00 Mn 6.44 2.19 Bn
62 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.85 Bn 0.00 Mn 77.53 2.41 Bn
63 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.66 Bn 0.00 Mn — 2.66 Bn
64 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.57 Bn 0.00 Mn — 2.57 Bn
65 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.53 Bn 0.00 Mn 4.72 2.17 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.45 Bn 0.00 Mn 44.81 1.76 Bn
67 HCM HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.43 Bn 0.00 Mn 3.41 2.43 Bn
68 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.41 Bn 0.00 Mn 46.31 2.41 Bn
69 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn 0.00 Mn 33.72 2.40 Bn
70 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.35 Bn 0.00 Mn — 2.09 Bn
71 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.25 Bn 0.00 Mn — 2.25 Bn
72 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn 0.00 Mn 111.21 2.22 Bn
73 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.22 Bn 0.00 Mn — 2.22 Bn
74 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.20 Bn 0.00 Mn 11.66 2.09 Bn
75 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.19 Bn 0.00 Mn 0.34 0.68 Bn
76 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.18 Bn 0.00 Mn 4.25 2.04 Bn
77 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.00 Mn — 1.77 Bn
78 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.14 Bn 0.00 Mn 57.61 1.87 Bn
79 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn 0.00 Mn 2,081.76 2.08 Bn
80 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.01 Bn 0.00 Mn 19.16 1.63 Bn
81 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.97 Bn 0.00 Mn 20.08 1.97 Bn
82 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.95 Bn 0.00 Mn 70.76 1.66 Bn
83 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn 0.00 Mn 1,492.89 1.94 Bn
84 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn 0.00 Mn 35.09 1.37 Bn
85 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.92 Bn 0.00 Mn 6.33 1.92 Bn
86 LKFT Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.88 Bn 0.00 Mn 1.63 1.88 Bn
87 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.87 Bn 0.00 Mn 4.35 0.99 Bn
88 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.86 Bn 0.00 Mn — 1.86 Bn
89 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.84 Bn 0.00 Mn 7.30 1.29 Bn
90 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.84 Bn 0.00 Mn 1,068.45 1.84 Bn
91 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.76 Bn 0.00 Mn — 1.76 Bn
92 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn 0.00 Mn — 1.18 Bn
93 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.69 Bn 0.00 Mn — 1.33 Bn
94 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.68 Bn 0.00 Mn 4.06 0.96 Bn
95 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn 0.00 Mn 16.71 1.65 Bn
96 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.62 Bn 0.00 Mn 8.12 1.33 Bn
97 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.61 Bn 0.00 Mn 2.25 1.32 Bn
98 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.59 Bn 0.00 Mn 525.18 1.59 Bn
99 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn 0.00 Mn — 1.23 Bn
100 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn — 1.57 Bn
101 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn 0.00 Mn 20.12 1.29 Bn
102 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.55 Bn 0.00 Mn 77.67 1.55 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn 0.00 Mn — 1.53 Bn
104 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.47 Bn 0.00 Mn — 1.47 Bn
105 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn 0.00 Mn — 1.46 Bn
106 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.43 Bn 0.00 Mn 172.15 0.93 Bn
107 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.42 Bn 0.00 Mn 49.60 0.79 Bn
108 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.39 Bn 0.00 Mn 892.27 1.19 Bn
109 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.38 Bn 0.00 Mn — 1.38 Bn
110 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn 35.69 1.37 Bn
111 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.37 Bn 0.00 Mn — 1.37 Bn
112 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn 0.00 Mn — 1.35 Bn
113 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 0.00 Mn — 1.34 Bn
114 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 0.00 Mn — 1.12 Bn
115 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 52.42 1.26 Bn
116 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn 0.00 Mn 3.19 1.14 Bn
117 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.21 Bn 0.00 Mn — 1.21 Bn
118 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.19 Bn 0.00 Mn — 1.19 Bn
119 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.10 Bn 0.00 Mn — 0.57 Bn
120 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 1.06 Bn 0.00 Mn — 1.06 Bn
121 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 5.58 0.92 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn 4.14 0.71 Bn
123 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 0.00 Mn — 0.95 Bn
124 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.99 Bn 0.00 Mn 15.15 0.62 Bn
125 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn 0.00 Mn — 0.97 Bn
126 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.93 Bn 0.00 Mn 2.06 0.65 Bn
127 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn 0.00 Mn 3.26 0.81 Bn
128 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 8.46 0.49 Bn
129 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 0.00 Mn 881.20 0.88 Bn
130 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 0.00 Mn 105.78 0.87 Bn
131 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.84 Bn 0.00 Mn — 0.84 Bn
132 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn 0.00 Mn 43.18 0.46 Bn
133 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.78 Bn 0.00 Mn 2.35 0.62 Bn
134 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.77 Bn 0.00 Mn — 0.77 Bn
135 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.72 Bn 0.00 Mn — 0.49 Bn
136 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.71 Bn 0.00 Mn — 0.64 Bn
137 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.70 Bn 0.00 Mn 1.80 0.62 Bn
138 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn 0.00 Mn 1,116.78 0.61 Bn
139 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.68 Bn 0.00 Mn 9.14 0.36 Bn
140 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 0.00 Mn 622.99 0.48 Bn
141 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn -0.37 Mn — 0.35 Bn
142 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.64 Bn 0.00 Mn — 0.64 Bn
143 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn — 0.61 Bn
144 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn 0.00 Mn 1.91 0.04 Bn
145 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 556.27 Mn 3.50 0.44 Bn
146 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 0.00 Mn 15.02 0.53 Bn
147 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 0.00 Mn — 0.57 Bn
148 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn 0.00 Mn — 0.57 Bn
149 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn 0.00 Mn — 0.54 Bn
150 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.54 Bn 0.00 Mn 23.87 0.25 Bn
151 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn 0.00 Mn 9.27 0.22 Bn
152 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn 0.00 Mn 78.36 0.26 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn — 0.49 Bn
154 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 13.97 0.24 Bn
155 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.55 0.42 Bn
156 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.49 Bn 0.00 Mn 2.10 0.39 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.48 Bn 0.00 Mn — 0.48 Bn
158 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.45 Bn
159 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 0.00 Mn — 0.47 Bn
160 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 0.00 Mn — 0.24 Bn
161 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn 15.39 0.26 Bn
162 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn 0.00 Mn — 0.45 Bn
163 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn 0.00 Mn 44.01 0.24 Bn
164 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn 0.00 Mn 41.35 0.43 Bn
165 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.41 Bn 0.00 Mn 6.30 0.22 Bn
166 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn 143.67 0.22 Bn
167 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn 0.00 Mn — 0.24 Bn
168 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
169 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn 0.00 Mn — 0.38 Bn
170 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.35 Bn 0.00 Mn 9.39 0.28 Bn
171 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn — 0.34 Bn
172 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 2.57 0.34 Bn
173 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn 0.00 Mn 3.74 0.17 Bn
174 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn 0.00 Mn 105.23 0.33 Bn
175 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.31 Bn 0.00 Mn — 0.31 Bn
176 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
177 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 64.15 0.30 Bn
178 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn 4.89 0.30 Bn
179 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.30 Bn 0.00 Mn — 0.30 Bn
180 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 0.00 Mn 12.87 0.29 Bn
181 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn 20.26 0.11 Bn
182 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn 0.00 Mn — 0.28 Bn
183 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn 1.64 0.16 Bn
184 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn 0.00 Mn — 0.15 Bn
185 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
186 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.26 Bn
187 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 61.83 0.26 Bn
188 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 22.51 0.26 Bn
189 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn 4.58 0.10 Bn
190 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn 0.00 Mn — 0.15 Bn
191 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 18.24 0.22 Bn
192 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn — 0.25 Bn
193 YDES YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 0.00 Mn 287.04 0.24 Bn
194 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn — 0.24 Bn
195 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn 0.00 Mn 3.25 0.15 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 0.00 Mn — 0.23 Bn
197 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
198 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 6.78 -0.04 Bn
199 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
200 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 10.27 0.08 Bn
201 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn 4.31 0.11 Bn
202 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 0.00 Mn — 0.22 Bn
203 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 90.16 0.10 Bn
204 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 32.66 0.21 Bn
205 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn — 0.19 Bn
206 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.63 0.17 Bn
207 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn 0.00 Mn 2.78 -0.01 Bn
208 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
209 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 0.00 Mn — 0.20 Bn
210 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn 0.00 Mn — 0.19 Bn
211 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 60.95 0.18 Bn
212 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn — 0.00 Bn
213 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn 0.00 Mn 2.77 0.04 Bn
214 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn 7.75 0.16 Bn
215 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn 0.00 Mn — 0.17 Bn
216 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn — — 0.00 Bn
217 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 33.37 0.16 Bn
218 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn 0.00 Mn 28.43 0.16 Bn
219 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn — 0.14 Bn
220 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 12.80 0.12 Bn
221 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn 0.00 Mn 1,899.21 -0.03 Bn
222 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
223 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn — — -0.02 Bn
224 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
225 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn 1,368.39 0.14 Bn
226 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 Mn — 0.14 Bn
227 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 136.44 0.13 Bn
228 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn — 0.13 Bn
229 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn 0.00 Mn 37.80 0.10 Bn
230 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn 41.31 0.12 Bn
231 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.01 Bn
232 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.11 Bn
233 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn 0.00 Mn — 0.06 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn 13.57 0.07 Bn
236 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn 0.00 Mn — 0.11 Bn
237 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.10 Bn
238 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn — 0.08 Bn
239 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 0.00 Mn 148.74 0.10 Bn
240 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
241 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
242 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn — — 0.09 Bn
243 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
244 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
245 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.08 Bn
246 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 1.26 -0.11 Bn
247 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn — 0.09 Bn
248 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn 0.00 Mn 55.22 0.09 Bn
249 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
250 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
251 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.05 Bn
252 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.08 Bn
253 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 0.00 Mn — 0.07 Bn
254 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 126.21 0.07 Bn
255 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn 1.49 0.02 Bn
257 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 Mn — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 0.43 0.02 Bn
259 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 16.90 0.03 Bn
260 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 3.26 -0.05 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn — 0.06 Bn
262 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn 0.00 Mn 29.64 0.06 Bn
263 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 1,552.32 0.05 Bn
264 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 5.23 0.00 Bn
265 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
266 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.05 Bn
267 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 3.86 0.05 Bn
268 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 294.15 -0.01 Bn
269 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn — 0.02 Bn
270 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn 0.00 Mn 2.19 0.05 Bn
271 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
272 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 330.85 0.02 Bn
273 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
274 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 83.41 0.04 Bn
275 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
276 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn 4.72 0.04 Bn
277 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.04 Bn
278 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 0.00 Mn — 0.03 Bn
279 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 4.53 0.03 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
281 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.95 0.02 Bn
282 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
283 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.92 0.03 Bn
284 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
285 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
286 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 0.35 0.03 Bn
287 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 93.50 0.03 Bn
288 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
289 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn — 0.03 Bn
290 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 36.27 0.03 Bn
291 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.00 Mn 755.61 0.02 Bn
292 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
294 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
295 GRDX GridAI Technologies Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 239.09 0.02 Bn
296 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
297 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 2.65 0.02 Bn
298 CNSY Cerenome, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn 4.53 0.01 Bn
299 KTTA Pasithea Therapeutics Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.02 Bn
300 CMMB Chemomab Therapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn 0.00 Mn — 0.01 Bn